CISD2 and metabolic dysfunction-associated steatotic liver disease: The gene CDGSH iron-sulfur domain 2 (CISD2), one of the pro-longevity genes that protects the liver from age-related pathological conditions and is a molecular target for NAFLD treatment [103], is downregulated in response to prenatal BPA in the liver, indicating an aging phenotype.